TMCI

Treace Medical Concepts, Inc. Common Stock

2.33

USD

TMCI Earnings Reports

Positive Surprise Ratio

TMCI beat 14 of 19 last estimates.

74%

Next Report

Date of Next Report

Feb 26, 2026

Estimate for Q4 25 (Revenue/ EPS)

$62.62M

-$0.15

Implied change from Q3 25 (Revenue/ EPS)

+24.70%

-42.31%

Implied change from Q4 24 (Revenue/ EPS)

-8.86%

+1400.00%

Treace Medical Concepts, Inc. Common Stock earnings per share and revenue

On Nov 06, 2025, TMCI reported earnings of -0.26 USD per share (EPS) for Q3 25, beating the estimate of -0.28 USD, resulting in a 8.96% surprise. Revenue reached 50.21 million, compared to an expected 50.73 million, with a -1.01% difference. The market reacted with a -28.33% price change (close before vs. close after earnings).

Looking ahead to Q4 25, 8 analysts forecast an EPS of -0.15 USD, with revenue projected to reach 62.62 million USD, implying an decrease of -42.31% EPS, and increase of 24.70% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Thermo Fisher Scientific, Inc.

Report Date

Jan 29, 2026 For Q4 25

Estimate

$6.51

Actual

$6.57

Surprise

+0.91%

Intuitive Surgical Inc.

Report Date

Jan 22, 2026 For Q4 25

Estimate

$2.30

Actual

$2.52

Surprise

+9.86%

Hologic Inc

Report Date

Jan 29, 2026 For Q1 26

Estimate

$1.11

Actual

$1.04

Surprise

-6.63%

FAQ

What were Treace Medical Concepts, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, Treace Medical Concepts, Inc. Common Stock reported EPS of -$0.26, beating estimates by 8.96%, and revenue of $50.21M, -1.01% below expectations.

How did the market react to Treace Medical Concepts, Inc. Common Stock's Q3 2025 earnings?

The stock price moved down -28.33%, changed from $6.23 before the earnings release to $4.46 the day after.

When is Treace Medical Concepts, Inc. Common Stock expected to report next?

The next earning report is scheduled for Feb 26, 2026.

What are the forecasts for Treace Medical Concepts, Inc. Common Stock's next earnings report?

Based on 8 analysts, Treace Medical Concepts, Inc. Common Stock is expected to report EPS of -$0.15 and revenue of $62.62M for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.